Announcements
- EUROBIO SCIENTIFIC SIGNS AN AGREEMENT TO ACQUIRE GENE EXPRESSION TEST FOR BREAST CANCER ENDOPREDICT®
- EUROBIO SCIENTIFIC SIGNE UN ACCORD POUR L'ACQUISITION DU TEST D'EXPRESSION GÉNIQUE POUR LE CANCER DU SEIN ENDOPREDICT®
- Eurobio Scientific : mise à disposition du rapport financier annuel 2023
- Eurobio Scientific : Rapport Financier Annuel 2023
- EUROBIO SCIENTIFIC: 2023 ANNUAL RESULTS
- EUROBIO SCIENTIFIC: RESULTAT ANNUEL 2023
- Eurobio Scientific: FISCAL YEAR 2023, STRATEGIC TRANSFORMATION OF THE GROUP
- Eurobio Scientific : EXERCICE 2023, CONFIRMATION DE LA TRANSFORMATION STRATEGIQUE
- EUROBIO SCIENTIFIC CONFIRME SON ELIGIBILITE AU DISPOSITIF PEA-PME
- Eurobio Scientific : BILAN SEMESTRIEL S2 DU CONTRAT DE LIQUIDITE
More ▼
Key statistics
As of last trade Eurobio Scientific SA (E8TN:DUS) traded at 14.78, 5.57% above its 52-week low of 14.00, set on Apr 30, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 14.78 |
---|---|
High | 14.78 |
Low | 14.78 |
Bid | 14.76 |
Offer | 15.16 |
Previous close | 14.44 |
Average volume | 0.00 |
---|---|
Shares outstanding | 10.25m |
Free float | 6.03m |
P/E (TTM) | 34.77 |
Market cap | 153.73m EUR |
EPS (TTM) | 0.4315 EUR |
Data delayed at least 15 minutes, as of May 23 2024 07:12 BST.
More ▼